Physician profile
Victor E Pena
NPI 1003994948
$922.38
in general payments reported to CMS, 2019-2025
16 companies · $54.50 in 2025
The $54.50 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $268 · 2020: $13.34 · 2021: $50.42 · 2022: $151 · 2023: $320 · 2024: $65.49 · 2025: $54.50.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $440.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $439.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $207.80 | 2019-2025 | Da Vinci Surgical System |
| Myriad Women'S Health, INC. | $185.93 | 2023 | Myrisk |
| Becton, Dickinson and Company | $147.73 | 2019 | |
| Ethicon US, LLC | $72.83 | 2020-2022 | |
| Pfizer INC. | $45.18 | 2022-2023 | |
| Abbvie INC. | $42.22 | 2022-2024 | |
| Astellas Pharma US INC | $38.08 | 2019-2024 | Veozah |
| Minerva Surgical, INC | $37.85 | 2023-2025 | |
| Shield Therapeutics INC | $25.74 | 2023 | Accrufer |
| Exeltis, USA INC. | $20.28 | 2021 | |
| Organon LLC | $19.00 | 2024 | |
| Mayne Pharma Commercial LLC | $18.67 | 2022 | |
| Therapeuticsmd, INC. | $17.87 | 2022 | |
| Scynexis, INC. | $17.53 | 2022 | |
| Sumitomo Pharma America, INC. | $13.10 | 2024 | Myfembree |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avion Pharmaceuticals | $12.57 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Victor Pena listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.